UNSPSC 51262000: Adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines

This classification denotes Adrenergic blocking agent drugs made from or based in part on butyrophenones, carbazoles, dibenzazepines, or dimethylamines

UNSPSC 51262000, Adrenergic blocking agent butyrophenones and carbazoles and dibenzazepines and dimethylamines (Class), does not align with the recent state and local procurement activity tagged under it. The one recent opportunity on record, Seminole County, Florida's IFB 60459723LAS, solicits naloxone and drug deactivation systems—emergency response and public health supplies—which fall outside the pharmaceutical active-ingredient scope the code's name suggests. The mismatch indicates either a coding error in the county's procurement system or a significant scope drift between the UNSPSC taxonomy and actual state and local buying practice under this code.

Seminole County posted the naloxone and deactivation-systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (an apparent date error in the record). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-Procurement Portal, drug-free workplace certification, E-Verify compliance, and standard insurance coverage. The contract carried a two-year initial term with a one-year renewal option and a three-month probationary termination window. The source provides no additional state or local opportunities under this code and no evidence of activity outside Florida.